The Point of Care Diagnostics Market Forecast 2014-2024

ポイントオブケア(POC)診断市場(2014-2024)

◆タイトル:The Point of Care Diagnostics Market Forecast 2014-2024
◆商品コード:Visiongain-405313
◆調査・発行会社:visiongain
◆発行日:2014年4月
◆ページ数:308
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single user licence(1名使用)GBP1,799 ⇒換算¥278,845見積依頼/購入/質問フォーム
Dept Licence(部署内共有可)GBP2,999 ⇒換算¥464,845見積依頼/購入/質問フォーム
Site Licence(同一国内社内共有可)GBP4,999 ⇒換算¥774,845見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"ポイントオブケア(POC)診断市場(2014-2024)"について調査・分析し、エグゼクティブサマリー、市場動向、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、種類別分析、市場環境分析、専門家の見解、主要企業分析、結論、提言などの情報をお届けいたします。

Point of care diagnostics – discover technological and commercial prospects
What does the future hold for the point of care diagnostics market? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.
Our 308 page report provides 173 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions.
Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT, Porter’s Five Forces and PESTEL), company profiles and commercial developments. Read the full transcripts of four exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
• Dr. Terenzio Facchinetti, Director Business Development, UL International GmbH
• Dr. Keith Batchelder, CEO and Founder of Genomic Healthcare Strategies (GHS), USA
• Dr. David Huckle, President and CEO of Adams Business Associates (ABA), UK
• Dr. Stephan Cohen-Bacrie, Co-director of the Multi-site Laboratory of Immunohematology and Immunogenetics, French Blood Establishment
You will find prospects for key submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of seven world-level submarkets to 2024:
• Blood glucose testing market
• Coagulation testing market
• Cardiac marker testing market
• Infectious diseases testing market
• Pregnancy testing market
• Cholesterol testing market
• Other point of care diagnostics markets
In general, each submarket is further segmented by components and discussions for leading regional markets within each submarket are also provided.
Our investigation shows business research and analysis with individual revenue forecasts and discussions. How will the point of care diagnostic markets expand? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.
What are the prospects in the leading regions and countries?
Events and progress worldwide will influence the market. In our study you will find individual revenue forecasts to 2024 for 15 national markets:
• US
• Japan
• Germany
• UK
• France
• Italy
• Spain
• Netherlands
• Belgium
• Switzerland
• Brazil
• Russia
• India
• China
• South Korea
• RoW
Many opportunities exist within the point of care diagnostics market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.
Additionally, you will find individual revenue forecasts to 2024 for 15 leading IVD national markets:
• US
• Germany
• France
• Italy
• Spain
• UK
• Netherlands
• Belgium
• Switzerland
• Japan
• China
• India
• South Korea
• Brazil
• Russia
• Row
Leading companies and potential for market growth
Overall world revenue for the point of care diagnostics market will reach $17.2bn in 2014, our work forecasts. We predict strong revenue growth from 2014 to 2024. Our work shows you what organisations hold greatest potential. See profiles of four leading companies, including these:
• Roche
• Abbott
• Siemens
• Alere
In general, a company profile gives you the following information:
• Overview of the company, including its history in the market
• Revenue forecasts from 2014 to 2024
• Discussion of a company’s activities and outlook including descriptions of leading products
• Recent financial results
• Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures
What issues will affect the point of care market?
Our new report discusses issues and events affecting the point of care market. You will find discussions, including qualitative analyses:
• An ever-growing patient population with chronic diseases
• An aging population
• Globalisation of infectious diseases and associated public health concerns
• Increasing demand for better monitoring and control of diseases
• Telehealth and remote communications between diagnostics and laboratories
• Global focus on personalised medicine
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How The Point of Care Diagnostics Market Forecast 2014-2024: Future Prospects for Leading Companies report helps you
In summary, our 307 page report gives you the following knowledge:
• Revenue forecasts to 2024 for the overall world point of care diagnostics market and 7 submarkets – discover the industry’s prospects, finding promising places for investments and revenues
• Assessment of leading companies, and others, discovering activities and outlooks
• Market forecasting to 2024 for 15 leading regions and countries in the POC diagnostics market and IVD market – USA, Japan, Germany, France, UK, Spain, Italy, Netherlands, Belgium, Switzerland, Brazil, Russia, China, India, South Korea and RoW.
• View opinions from our survey, seeing 4 interviews with leading authorities
• Investigation of competition and opportunities influencing sales
• Discussion of what stimulates and restrains the point of care diagnostics market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.
visiongain’s study is for everybody needing commercial analyses for the point of care diagnostics market. You find data, trends and predictions. Please order our report now.

【レポートの目次】

1. Executive Summary
1.1 The Point of Care (POC) Diagnostics Market Highlights
1.2 Chapter Outlines
1.2.1 Aims, Scope and Format of the Report
1.3 Research and Analysis Methods
2. Introduction to In-Vitro Diagnostics and POC Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 IVD Classification in Australia
2.2.3 EDMA Classification
2.2.3.1 Clinical Chemistry: Not To Be Discounted
2.2.3.2 Immunochemistry
2.2.3.3 Haematology
2.2.3.4 Microbiology
2.2.3.5 Genetic Testing
2.2.3.6 Point Of Care Diagnostics: The Most Prominent Type
2.3 Diagnostics Regulation of the IVD and POC Market
2.3.1 FDA and CLIA Regulation of IVD and POC Tests
2.3.2 Regulation of IVD/POC Diagnostics in the EU: The EC (European Commission) Classification
2.4 Regulation for In-Vitro Diagnostics and POC Diagnostics
2.4.1 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.2 Device Excise Tax: A Threat to the Diagnostics Manufacturers
2.5 Uses of Point of Care (POC) Diagnostics
2.6 Advantages and Disadvantages of POC Diagnostics
3. The Point of Care Diagnostics Market, 2014-2024
3.1 Scope of this Report
3.2 Point of Care Diagnostics in the IVD Market, 2013
3.3 The World Point of Care Diagnostics Market in 2013
3.3.1 Self Testing Constituted the Largest Segment in the POC Market by the Point of Delivery
3.3.2 Point of Care Diagnostics Market Segmentation
3.4 The Global IVD Market: Sales Forecast, 2014-2024
3.4.1 Which Segments Will Drive the Global IVD Market in the Next 10 Years?
3.5 The Global Clinical Diagnostics Market Forecast, 2014-2024
3.6 The Global Point of Care Diagnostics Market: Sales Forecast 2014-2024
3.6.1 The Drive of Personalised Medicine
3.7 Market for POC Diagnostics Products: Leading Segments to 2024
3.7.1 Breakdown of the World Point of Care Diagnostics Main Submarkets: Changing Shares 2014-2024
3.7.2 Blood Glucose Testing Market Forecast 2014-2024
3.7.3 Infectious Diseases Testing Market Forecast 2014-2024
3.7.4 Rapid Coagulation Testing Market Forecast 2014-2024
3.7.5 Rapid Cardiac Marker Testing Market Forecast 2014-2024
3.7.6 Cholesterol Testing Market Forecast 2014-2024
3.7.7 Pregnancy Testing Market Forecast 2014-2024
3.7.8 Other Segments Market Forecast 2014-2024
3.7.8.1 Cancer Diagnostics Will Be a Major Driver for This Segment
3.7.8.2 The Haematology Market Will Be Driven by Blood Gas Tests
3.7.8.3 A Recently Discovered Biomarker for Sepsis Can Set The Potential For A Future Rapid Blood Test
3.8 Scope of the Point of Care Diagnostics Market
3.9 Which Point of Care Diagnostic Segment Holds the Greatest Potential?
3.9.1 The Point of Care Diagnostics Market: Drivers and Restraints 2014-2024
4. Leading National Point of Care Diagnostics Markets 2014-2024
4.1 Regional Breakdown of the World IVD Market: Sales Forecast by Country 2014-2024
4.2 Regional Breakdown of the World Point of Care Diagnostics Market in 2013
4.3 The World POC Diagnostics Market: Regional Forecasts 2014-2024
4.4 How Will Regional Market Shares Change to 2024?
4.5 The US POC Diagnostics Market, 2013
4.5.1 The US Will Still Dominate the POC Diagnostics Market in 2024
4.5.2 The US POC Diagnostics Market Forecast 2014 – 2024
4.5.3 Healthcare Expending in the US
4.5.4 The US POC Diagnostics Market: Drivers and Restraints
4.6 The Leading European POC Diagnostics Markets: Sales Forecasts 2014-2024
4.6.1 Variation in the European POCT Markets, 2014-2024
4.6.2 The German POC Diagnostics Market Forecast, 2014-2024
4.6.3 The UK POC Diagnostics Market Forecast 2014-2024
4.6.4 The French POC Diagnostics Market Forecast 2014-2024
4.6.5 The Italian POC Diagnostics Market Forecast 2014-2024
4.6.6 The Spanish POC Diagnostics Market Forecast 2014-2024
4.6.7 The Netherlands POC Diagnostics Market Forecast 2014-2024
4.6.8 The Belgian POC Diagnostics Market Forecast 2014-2024
4.6.9 The Swiss POC Diagnostics Market Forecast 2014-2024
4.7 The Japanese POC Diagnostics Market Forecast 2014-2024
4.7.1 The Japanese POC Diagnostics Market Overview 2014-2024
4.8 The BRICK Nations POC Diagnostics Market
4.8.1 The BRICK Nations POC Diagnostics Market: Overview
4.8.2 How Will BRICK Market Shares Change to 2024?
4.8.3 The BRICK Nations POC Diagnostics Market Forecast 2014-2014
4.8.3.1 The Chinese POCT Market Overview: Advances in China Lead to Expansion of the Market 4.8.3.1.1 The Chinese POC Diagnostics Market Forecast 2014-2024
4.8.3.2 The Indian POC Diagnostics Market Overview
4.8.3.2.1 The Indian POC Diagnostics Market Forecast 2014-2024
4.8.3.3 The South Korean POC Diagnostics Market Forecast 2014-2024
4.8.3.4 The Brazilian POC Diagnostics Market Forecast 2014-2024
4.8.3.5 The Russian POC Diagnostics Market Forecast 2014-2024
4.9 Rest of the World POC Diagnostics Markets Forecasts 2014-2024
4.9.1 Further Insights: Point of Care Diagnostics Approach for Developing Countries
5. Global Blood Glucose Testing Market, 2014-2024
5.1 POC Blood Glucose Testing Market Overview
5.2 Global POC Blood Glucose Testing Market, 2013
5.3 POC Blood Glucose Testing Market Forecast 2014-2024
5.3.1 POC Blood Glucose Testing Market by Type of Meter
5.3.2 POC Blood Glucose Testing Market Segment by Components
5.3.2.1 POC Blood Glucose Testing Devices Currently Available in the Market, 2014
5.3.3 Leading Regional Markets in the POC Blood Glucose Testing Market, 2013
5.3.4 Leading Companies in the POC Blood Glucose Testing Market, 2014
5.3.4.1 Other Companies in the POC Blood Glucose Testing Market: Recent Advances
5.3.5 Market Prospects to 2024: Which Product Will Lead the Market?
5.3.5.1 Advantages and Disadvantages of the Current CGM Tests in the Market
5.4 Drivers and Restraints for the POC Blood Glucose Testing Market, 2014-2024
6. Global Coagulation Testing Market, 2014-2024
6.1 Global POC Coagulation Testing Market: Overview
6.2 Global POC Coagulation Testing Market in 2013
6.2.1 PT/INR Monitoring is the Largest Segment in the POC Coagulation Testing Market
6.3 Products Available in the POC Coagulation Testing Market, 2014
6.3.1 Patient Self Testing is a Fastest Growing Segment
6.4 POC Coagulation Testing Market Segment by Components
6.4.1 Test Strips Generate 85% of the Sales in the PT/INR POC Testing Market
6.5 POC Coagulation Testing Market by Type of Drug
6.5.1 Anticoagulants
6.5.2 Heparins
6.5.3 Vitamin K Antagonists
6.5.4 Direct Thrombin Inhibitors
6.5.5 Direct Factor Xa Inhibitors
6.6 The POC Coagulation Testing Market by Regions, 2013
6.7 POC Coagulation Testing Market Forecast 2014-2024
6.8 Leading Companies in the POC Coagulation Testing Market, 2014
6.8.1 Roche Dominated the POC Coagulation Testing Market with CoaguChek XS System in 2013
6.8.2 Market Prospects to 2024: Who Will Be The Leading Product?
6.9 Drivers and Restraints for the POC Coagulation Testing Market, 2014-2024
7. Global Cardiac Marker Testing Market, 2014-2024
7.1 Cardiac Marker Diagnostic Testing Market: Overview
7.1.1 The Majority of Cardiac Marker Testing is Conducted in Critical Care Settings
7.2 The Global Cardiac Marker Diagnostic Testing Market 2013
7.3 Cardiac Marker Diagnostic Testing Market Forecast 2014-2024
7.3.1 Leading Regional Markets in the Cardiac Marker Diagnostic Testing, 2013
7.3.1.1 Global Deaths Due to CVD in High, Middle and Low Income Countries, 2014
7.3.2 Leading Companies in the Cardiac Marker Diagnostic Testing Market, 2014
7.3.3 Cardiac Marker Diagnostic Tests Currently Under Development, 2014
7.3.3.1 cobas h232 Cardiac Marker (Roche)
7.3.3.2 QL Care Analyzer (CardioGenics)
7.3.3.3 Handheld Device (bioMerieux/Royal Philips Electronics)
7.3.4 Cardiac Marker Diagnostic Testing Market: Leading Products
7.3.5 Which Company is Dominating the Market?
7.3.6 A Leading Product: Abbott’s i-STAT
7.4 Drivers and Restraints for the Cardiac Marker Diagnostic Testing Market, 2014-2024
7.4.1 Challenges for the New Entrants in the Cardiac Markers Diagnostic Testing Market
8. Global Infectious Diseases Testing Market, 2014-2024
8.1 POC Infectious Diseases Testing Market: Overview
8.2 Global POC Infectious Diseases Testing Market, 2013
8.2.1 Breakdown of the POC Infectious Diseases Testing Market by Diseases, 2013
8.2.1.1 Influenza/Flu
8.2.1.2 HIV
8.2.1.3 Hepatitis
8.2.1.4 Tuberculosis
8.2.1.5 Sexually Transmitted Diseases
8.3 The POC Infectious Diseases Testing Market: Leading Products 2014
8.3.1 HIV Leading POC Diagnostics Products, 2014
8.3.1.1 HIV Diagnostics Kits Approved by the FDA, 2014
8.3.2 The HIV Rapid Testing Market in the US, 2014
8.3.3 HIV POC Tests Pipeline, 2014
8.3.4 Driving Factors for Growth of HIV Rapid Testing: Past and Future
8.4 The Hepatitis POC Testing Market
8.4.1 First Rapid HCV Test Approved in the US
8.4.2 The Influenza POC Testing Market and Leading Companies, 2014
8.4.3 Driving Factors for Growth of Hepatitis Rapid Testing
8.4.4 POC Infectious Diseases Recent Trends
8.4.4.1 OraQuick Marker, OraSure Technologies: First OTC Home-Use Rapid HIV Test Approved by the FDA
8.4.4.2 Determine HIV-1/2 Ag/Ab Combo Test, Alere: First Rapid Diagnostic Test to Detect Both HIV-1 Antigen And HIV-1/2 Antibodies
8.4.5 Leading Regional Markets in the POC Infectious Diseases Testing
8.4.5.1 Infectious Diseases POC Testing: Regional Markets in 2013
8.5 Infectious Diseases POC Testing Market: Leading Companies 2014
8.6 The POC Infectious Diseases Testing Market Forecast, 2014-2024
8.7 Drivers and Restraints for the POC Infectious Diseases Testing Market, 2014-2024
9. Global Pregnancy Testing Market, 2014-2024
9.1 The POC Pregnancy Testing Market: Overview
9.2 Global POC Pregnancy Testing Market, 2013
9.3 The POC Pregnancy Testing Market Forecast 2014-2024
9.3.1 The POC Pregnancy Testing Market: Leading Products 2014
9.3.2 Leading Companies in the POC Pregnancy Testing Market, 2014
9.4 Drivers and Restraints for the POC Pregnancy Testing Market, 2014-2024
10. Global Cholesterol Testing Market, 2014-2024
10.1 Global POC Cholesterol Testing Market: Overview
10.2 The Global POC Cholesterol Testing Market in 2013
10.3 The POC Cholesterol Testing Market Forecast 2014-2024
10.3.1 POC Cholesterol Testing Biomarkers: Overview
10.3.2 The POC Cholesterol Testing Market by Components
10.3.3 Recent Developments in the POC Cholesterol Testing Market, 2014
10.3.3.1 New Product 2014: Roche’s Accutrend Plus
10.3.4 POC Cholesterol Testing Market: Considerations in Production
10.4 Drivers and Restraints for the POC Cholesterol Testing Market, 2014-2024
11. Leading Companies in the POC Diagnostics Market, 2014
11.1 Leadng POC Diagnostics Companies in 2014
11.2 Roche: Overview
11.2.1 Roche: Global Presence
11.2.2 Roche Diagnostics, 2014-2024
11.2.2.1 Roche Business Performance within the IVD Market, 2013
11.2.2.2 Roche Diagnostics Market Forecast 2014-2024
11.2.3 Roche Diagnostics: Key Launches Planned for 2014
11.2.4 Roche Diagnostics: POC Product Portfolio
11.2.5 Roche: Recent M&A Activity and Strategic Collaborations
11.3 Abbott: Continuously Transforming to Meet the Changing Needs
11.3.1 Abbott: Market Leader in the Coronary DES Sector
11.3.2 Abbott Diagnostics: Overview, 2013
11.3.2.1 Abbott Diagnostics: Leading Point-of-Care Platform
11.3.3 Abbott’s Fast Growing Diagnostics Division: Sales Forecast 2014-2024
11.3.4 Abbott Portfolio Sales and Recent Performance Analysis
11.3.5 Abbott: The i-STAT System
11.3.5.1 Recent M&A Activity and Strategic Collaborations
11.3.5.1.1 Abbott Laboratories Agreed to Acquire IDEV Technologies
11.3.5.1.2 Collaboration with Merck
11.3.5.2 Abbott IVD Segment: Strengths & Challenges
11.4 Siemens: A Highly Diversified Company
11.4.1 Siemens Healthcare: Prospects within the IVD Market
11.4.2 Siemens Healthcare: Sales Forecast 2014-2024
11.4.3 Siemens Healthcare: POC Diagnostics Product Portfolio
11.4.3.1 Siemens Healthcare Diagnostics Recent Trends, 2014
11.4.3.2 Recent M&A Activity and Strategic Collaborations
11.5 Alere Inc: A Strong Player
11.5.1 Alere Inc Performance Analysis in 2013
11.5.2 Alere Inc: Performance in Geographic Markets in 2013
11.5.3 Alere Inc.: Product Profile Overview
11.5.4 Alere’s Professional Diagnostics Market in 2013
11.5.5 Product Profile Recent Trends, 2014
11.5.6 Alere Market Forecast 2014-2024
11.5.7 Alere: Recent M&A Activity and Strategic Collaborations
11.6 Other Companies of Interest: Recent M&A Activity and Strategic Collaborations, 2014
12. Qualitative Analysis of the POC Diagnostics Market, 2014-2024
12.1 Introduction
12.2 Drivers and Restraints for the POC Diagnostics Market
12.2.1 Commercial Drivers
12.2.2 Commercial Restraints
12.3 Strategic Review of the POC Diagnostics Market
12.4 Pestel Analysis
12.4.1 Political Factors
12.4.2 Economic Factors
12.4.3 Socio-Cultural Factors
12.4.4 Technological Factors
12.4.5 Environmental Factors
12.4.6 Legal Factors
12.5 P5F Analysis
12.5.1 Competitive Rivalry
12.5.2 Rivalry Among Competitors: [High] Diagnostics is a Promising Market
12.5.3 Potential Entrants into the POC Diagnostics Market
12.5.3.1 Threat of New Entrants: [Medium] Continuous Arousal of Innovations in the POCT Market
12.5.4 Who Are The Latent Substitutes?
12.5.5 Threat of Substitutes: [Medium]New Technologies Might Limit the Need to Monitor Diseases
12.5.6 Vertical Integration With Suppliers and Buyers
12.5.6.1 Power of Suppliers: [Medium] Increased Competition Outweigh Suppliers
12.5.6.2 Power of Buyers: [High] Demand and Health Systems Will Go Hand by Hand
12.6 SWOT Analysis and Strategies
12.6.1 Strengths: Timing is First
12.6.2 Weaknesses: Awaiting Expanded Reimbursement Options
12.6.3 Opportunities: A Promising Market
12.6.4 Threats: Unmet Needs in the Low-Middle Income Countries
13. Expert Opinions
13.1 Interview with Dr. Terenzio Facchinetti, Director Business Development of UL Life and Health, UL International GmbH, Germany.
13.1.1 Impact of Remote Access on the POCT Market
13.1.2 UL’s Life and Health Business Unit: A Global Independent Safety Science Company
13.1.3 The Importance of Standardization and Regulations for the POC Market
13.1.4 Recommendations for the Future of POC Diagnostics: What to Expect
13.2 Interview with Dr. Keith Batchelder, CEO and Founder of Genomic Healthcare Strategies (GHS), USA.
13.2.1 Advantages of POC Diagnostics
13.2.2 Restraints of POC Diagnostics
13.2.3 About Genomic Healthcare Strategies
13.2.4 US has the Highest Potential for the POC Diagnostics Market
13.2.5 Remarkable Insights
13.3 Interview with Dr. David Huckle, President and CEO of Adams Business Associates (ABA), UK.
13.3.1 Remarkable Understanding on the POC Diagnostics Market
13.3.2 The Expert’s Perspective: Drivers and Restraints for POC Diagnostics
13.3.3 Recommendations for the Future POC Diagnostics Market
13.3.4 Further Insights from Dr. Huckle: Leading Companies
13.4 Interview with Dr. Stéphan Cohen-Bacrie, Co-director of the Multi-site Laboratory of Immunohematology and Immunogenetics, French Blood Establishment, Burgundy-FrancheComté, France.
13.4.1 The French POC Diagnostics Market: Experienced Perspective
13.4.2 Restraints in the POC Diagnostics Market
13.4.3 The Advantage of Molecular Diagnostics
13.4.4 Innovations in Rural Africa: POC-labs
13.4.5 R&D in Focus: The Syndromic Panels and Microfluidics-based Methods
13.4.6 Where is the POC Diagnostics Market Heading?: An Expert’s View
14. Conclusions
14.1 Overview
14.2 The POC Testing in the IVD Market
14.3 The World POC Diagnostics Market Forecast 2014-2024
14.3.1 Leading Regional Markets Forecast 2014-2024
14.4 The World POC Diagnostics Market Forecast 2014-2024
14.5 POC Diagnostic Segments: Positions in the Market 2014
14.5.1 Current Advantages in POC Diagnostics
14.5.1.1 Comparison with Laboratory Testing
14.5.2 Leading POC Diagnostics Companies, 2014
14.6 Commercial Drivers for the Adoption of POC Tests
14.6.1 Commercial Restraints in the POC Diagnostics Market
14.7 Challenges for POC Diagnostics
14.8 The Future of the POC Diagnostics and Concluding Remarks

13.2.5 Remarkable Insights
13.3 Interview with Dr. David Huckle, President and CEO of Adams Business Associates (ABA), UK.
13.3.1 Remarkable Understanding on the POC Diagnostics Market
13.3.2 The Expert’s Perspective: Drivers and Restraints for POC Diagnostics
13.3.3 Recommendations for the Future POC Diagnostics Market
13.3.4 Further Insights from Dr. Huckle: Leading Companies
13.4 Interview with Dr. Stéphan Cohen-Bacrie, Co-director of the Multi-site Laboratory of Immunohematology and Immunogenetics, French Blood Establishment, Burgundy-FrancheComté, France.
13.4.1 The French POC Diagnostics Market: Experienced Perspective
13.4.2 Restraints in the POC Diagnostics Market
13.4.3 The Advantage of Molecular Diagnostics
13.4.4 Innovations in Rural Africa: POC-labs
13.4.5 R&D in Focus: The Syndromic Panels and Microfluidics-based Methods
13.4.6 Where is the POC Diagnostics Market Heading?: An Expert’s View
14. Conclusions
14.1 Overview
14.2 The POC Testing in the IVD Market
14.3 The World POC Diagnostics Market Forecast 2014-2024
14.3.1 Leading Regional Markets Forecast 2014-2024
14.4 The World POC Diagnostics Market Forecast 2014-2024
14.5 POC Diagnostic Segments: Positions in the Market 2014
14.5.1 Current Advantages in POC Diagnostics
14.5.1.1 Comparison with Laboratory Testing
14.5.2 Leading POC Diagnostics Companies, 2014
14.6 Commercial Drivers for the Adoption of POC Tests
14.6.1 Commercial Restraints in the POC Diagnostics Market
14.7 Challenges for POC Diagnostics
14.8 The Future of the POC Diagnostics and Concluding Remarks
List of Tables
Table 2.1Types of Genetic In Vitro Diagnostic Tests Currently Available, 2013
Table 2.2 Advantages and Disadvantages of POC Diagnostics, 2014
Table 3.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2013
Table 3.2 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Type of Delivery, 2013
Table 3.3 The POC Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2013
Table 3.4 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 3.5 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Segments, 2013-2024
Table 3.6 The Clinical Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 3.7 The Global POC Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 3.8 World POC Diagnostics Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Segment, 2013-2024
Table 3.9 The Global POC Diagnostics Market: Shares (%), by Segment, 2013, 2018 and 2024
Table 4.1 IVD Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), by Country, 2013-2024
Table 4.2 The POC Diagnostics Market: Revenue ($bn) and Market Shares (%) by Regional Markets, 2013
Table 4.3 POC Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), by Region, 2013-2024
Table 4.4 The Global POC Diagnostics Market: Shares (%), by Regional Markets, 2013, 2018 and 2024
Table 4.5 US POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.6 European POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), by Country, 2013-2024
Table 4.7 The German POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.8 The UK POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.9 The French POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.10 The Italian POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.11 The Spanish POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.12 The Netherlands POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.13 The Belgian POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.14 The Swiss POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.15 The Japanese POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.16 The BRICK Countries POC Diagnostics Market Forecasts: Sales Revenue ($bn), AGR (%) and CAGR (%), by Country, 2013-2024
Table 4.17 The Chinese POC Diagnostics Market Forecasts: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.18 The Indian POC Diagnostics Market Forecasts: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.19 The South Korean POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.20 The Brazilian POC Diagnostics Market Forecasts: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.21 The Russian POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 4.22 ROW POC Diagnostics Market Forecast: Sales Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 5.1 Global POC Blood Glucose Testing Devices Market , Revenue ($bn) and Share (%), 2013
Table 5.2 The Global POC Blood Glucose Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 5.3 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Type of Meter, 2013
Table 5.4 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Components, 2013
Table 5.5 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company, 2014
Table 5.6 Leading National Markets for the POC Blood Glucose Testing Market, Revenue ($bn) and Shares (%), 2013
Table 5.7 Main Product of the Diabetes Care Business Segment, Revenue ($bn) and Shares (%), by Leading Companies, 2013
Table 5.8 List of Some Other Companies in the POC Blood Glucose Testing Market, 2014
Table 5.9 Advantages of CGMs over Fingerstick Testing Systems, 2014
Table 5.10 Advantages and Disadvantages of the Currently Available CGM, by Product, 2014
Table 6.1 Global POC Coagulation Testing Market, Revenue ($bn) and Share (%), 2013
Table 6.2 List of Some Products in the POC Coagulation Testing Market for Self Testing and Professional Testing, 2014
Table 6.3 The PT/INR POC Testing Market, Revenue ($m) and Shares (%), by Point of Use, 2013
Table 6.4 The Price of Some PT/INR POC Testing Systems ($), 2014
Table 6.5 PT/INR POC Testing Market, Revenue ($m) and Shares (%), by Components, 2013
Table 6.6 The Global POC Coagulation Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 7.1 Global Cardiac Marker Diagnostic Testing Market, Revenue ($bn) and Share (%), 2013
Table 7.2 Time to Elevation for Some Cardiac Markers, 2014
Table 7.3 Clinical Use of the Cardiac Biomarkers, 2014
Table 7.4 The Global Cardiac Marker Diagnostic Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 7.5 Companies Developing Cardiac Biomarkers, 2014
Table 7.6 Leading Products in the Cardiac Marker Diagnostic Testing Market, by Company, 2014
Table 8.1 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2013
Table 8.2 POC Infectious Disease Market: Revenues ($bn), by Disease, 2013
Table 8.3 Strengths and Limitations of Some Leading Products in the HIV Rapid Testing Market , 2014
Table 8.4 FDA Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2014
Table 8.5 The US HIV Rapid Testing Market, Revenue ($m) and Shares (%), by Leading Products, 2013
Table 8.6 List of Some HIV POC Tests Under Development, 2014
Table 8.7 List of Some Products in the POC Hepatitis Testing Market, 2014
Table 8.8 List of Some Products in the Rapid Influenza Testing Market, 2014
Table 8.9 The Global POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 9.1 Global POC Pregnancy Testing Market, Revenue ($bn) and Share (%), 2013
Table 9.2 The Global POC Pregnancy Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 10.1 Global POC Cholesterol Testing Market, Revenue ($bn) and Share (%), 2013
Table 10.2 The Global POC Cholesterol Testing Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 11.1 Roche Diagnostics: Revenue ($m) and Revenue Share (%), by Business Area, 2013
Table 11.2 Roche Diagnostics Revenue Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 11.3 Roche Diagnostics: Key Product Launches Planned for 2014
Table 11.4 Abbott Diagnostics: Revenues ($m) and Revenue Shares (%), by Business Segment, 2013
Table 11.5 Abbott Diagnostics Revenue Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 11.6 Siemens: Revenue ($m) and Revenue Shares (%), by Business Sectors, 2013
Table 11.7 Siemens Healthcare Revenue Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2013-2024
Table 11.8 Siemens Healthcare: Point of Care Testing Products Range, 2014
Table 11.9 Alere Inc. Revenue ($m) and Revenue Shares (%), by Business Segment, 2013
Table 11.10 Alere Inc. Revenue ($m) and Revenue Shares (%), by Geographic Location, 2013
Table 11.11 Alere Inc: Professional Diagnostics Product Portfolio Overview for Each Segment, 2014
Table 11.12 Description of the Product Portfolio for Alere Inc., 2014
Table 11.13 Alere Professional Diagnostics Segment: Revenue ($m) and Revenue Shares (%), by Group, 2013
Table 11.14 Alere Professional Diagnostics Forecast: Sales ($bn), AGR (%) and CAGR (%), 2013-2024
Table 12.1 SWOT Analysis of the POC Diagnostics Market, 2014-2024


List of Figures
Figure 3.1 Global IVD Market Shares (%) by Segment, 2013
Figure 3.2 Global IVD Market Revenues ($bn) for Clinical Diagnostics and POC Diagnostics Segments, 2013
Figure 3.3 Market Share (%) and Market Size ($bn) of Self Testing/OTC and Professional Testing in the POC Market, 2013
Figure 3.4 The POC Diagnostics Market: Shares (%) by Segments, 2013
Figure 3.5 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 3.6 The IVD Diagnostics Market Forecast: Revenue ($bn), by Segments, 2013-2024
Figure 3.7 The Clinical Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 3.8 The Global POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 3.9 World POC Diagnostics Market Forecast: Revenues ($bn), by Segment, 2013-2024
Figure 3.10 World POC Diagnostics Market: CAGR (%), by Segment, 2013-2024
Figure 3.11 The POC Diagnostics Market Shares (%), by Segments, 2013
Figure 3.12 The POC Diagnostics Market Shares (%), by Segments, 2018
Figure 3.13 The POC Diagnostics Market Shares (%), by Segments, 2024
Figure 3.14 The POC Diagnostics Market Shares (%), by Segments (excld. Blood Glucose Market), 2013-2024
Figure 3.15 Scope of The POC Diagnostics Market: Revenue ($bn) and CAGR (%), by Segments, 2013
Figure 3.16 The POC Diagnostics Market: Drivers and Restraints, 2014-2024
Figure 4.1 World POC Diagnostics Market: Revenue ($bn), by Regional Markets, 2013
Figure 4.2 POC Diagnostics Market: Sales Revenue ($bn), by Region, 2013- 2024
Figure 4.3 POC Diagnostics Sales Shares (%) in Leading Regional Markets, 2013
Figure 4.4 POC Diagnostics Sales Shares (%) in Leading Regional Markets, 2018
Figure 4.5 POC Diagnostics Sales Shares (%) in Leading Regional Markets, 2024
Figure 4.6 The US POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.7 US IVD Market: Drivers and Restraints, 2014-2024
Figure 4.8 European POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.9 The German POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.10 The UK POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.11 The French POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.12 The Italian POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.13 The Spanish POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.14 The Netherlands POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.15 The Belgian POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.16 The Swiss POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.17 The Japanese POC Diagnostics National Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.18 The BRICK Nations POC Diagnostics Market Shares (%), by Country, 2013
Figure 4.19 The BRICK Nations POC Diagnostics Market Shares (%), by Country, 2018
Figure 4.20 The BRICK Nations POC Diagnostics Market Shares (%), by Country, 2024
Figure 4.21 The BRICK Countries POC Diagnostics Market Forecasts: Sales Revenue ($bn) and AGR (%), by Country, 2013-2024
Figure 4.22 The Chinese POC Diagnostics Market Forecasts: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.23 The Indian POC Diagnostics Market Forecasts: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.24 The South Korean POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.25 The Brazilian POC Diagnostics Market Forecasts: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 4.26 The Russian POC Diagnostics Market Forecast: Sales Revenue ($bn) and AGR (%), 2013-2024
Figure 5.1 The Global POC Blood Glucose Testing Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 5.2 Market Shares (%) of Fingerstick Testing and CGM Devices in the POC Blood Glucose Monitoring Market, 2013
Figure 5.3 Market Shares (%) of Devices, Test Strips and Other Devices in the POC Blood Glucose Testing Market, 2013
Figure 5.4 Market Shares (%) of Leading National Markets in the POC Blood Glucose Testing Market, 2013
Figure 5.5 Sales Revenues ($bn) for the Diabetes Care Business Segment, Revenue ($bn) and Shares (%), by Leading Companies, 2013
Figure 5.6 POC Blood Glucose Testing Market: Drivers and Restraints, 2014-2024
Figure 6.1 The PT/INR POC Testing Market by Point of Use, Market Share (%), 2013
Figure 6.2 PT/INR POC Testing Market Shares (%), by Components, 2013
Figure 6.3 The Global POC Coagulation Testing Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 6.4 The POC Coagulation Testing Market: Drivers and Restraints, 2014-2024
Figure 7.1 The Global Cardiac Marker Diagnostic Testing Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 7.2 Global Fraction of Deaths Due to Cardiovascular Diseases in High, Middle and Low Income Countries
Figure 7.3 Pipeline of Cardiac Markers Diagnostics Tests Currently in Development, 2014
Figure 7.4 Market Share (%) of cobas h232, i-STAT and RAMP in the Global Cardiac Marker Diagnostic Testing Market, 2013
Figure 7.5 Cardiac Marker Diagnostic Testing Market: Drivers and Restraints, 2014-2024
Figure 8.1 The POC Infectious Disease Market Shares (%), by Disease, 2013
Figure 8.2 Market Share (%) of Leading Products in the US HIV Rapid Testing Market, 2013
Figure 8.3 The Global POC Infectious Diseases Testing Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 8.4 POC Infectious Diseases Testing Market: Drivers and Restraints, 2014-2024
Figure 9.1 The Global POC Pregnancy Testing Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 9.2 The POC Pregnancy Testing Market: Drivers and Restraints, 2014-2024
Figure 10.1 The Global POC Cholesterol Testing Market Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 10.2 The POC Cholesterol Testing Market: Drivers and Restraints, 2014-2024
Figure 11.1 Roche Diagnostics: Revenues ($m) by Business Area, 2013
Figure 11.2 Roche Diagnostics: Revenue Share (%) by Business Area, 2013
Figure 11.3 Roche Diagnostics Revenue Forecast: Sales ($bn) and AGR (%), 2013-2024
Figure 11.4 Abbott Diagnostics: Revenue ($m), by Business Segment, 2013
Figure 11.5 Abbott Diagnostics: Revenue Shares (%), by Business Segment, 2013
Figure 11.6 Abbott Diagnostics Revenue Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 11.7 Siemens: Revenue Shares (%), by Business Sector, 2013
Figure 11.8 Siemens Healthcare Revenue Forecast: Revenue ($bn) and AGR (%), 2013-2024
Figure 11.9 Alere Inc. Revenue Shares (%), by Business Segment, 2013
Figure 11.10 Alere Inc. Revenue Shares (%), by Geographic Location, 2013
Figure 11.11 Alere Professional Diagnostics Segment: Revenue Shares (%), by Group, 2013
Figure 11.12 Alere Professional Diagnostics Forecast: Sales ($bn) and AGR (%), 2013-2024
Figure 12.1 Drivers and Restraints For The POC Diagnostics Market
Figure 12.2 Relationship Between PESTEL, PSF and SWOT
Figure 12.3 Porter’s Five Forces Analysis of the POC Diagnostics Market, 2014-2024
Figure 13.1 The Factors That Can Limit the Growth of POC Diagnostics
Figure 14.1The Classification of POC Diagnostics
Figure 14.2 The World IVD Market: Shares (%), by Segments, 2013
Figure 14.3 The World POC Diagnostics Market Forecast, Revenue ($bn) and AGR (%) 2013-2024
Figure 14.4 The POC Diagnostics Regional Market Forecast: Revenue ($bn), by Regional Markets, 2014-2024
Figure 14.5 The World POC Diagnostics Regional Market Shares (%), by Country, 2013, 2018 and 2024
Figure 14.6 The World POC Diagnostics Market Forecast: Sales Revenue ($bn), by Segments, 2013-2024
Figure 14.7 Position in the Market for the POC Diagnostics Market: by Segments, 2013
Figure 14.8 Sales Revenue ($bn) of Some of the Leading POC Diagnostics Companies, 2013
Figure 14.9 SWOT Analysis Results for the Global POC Diagnostics Market, 2014-2024


【掲載企業】

1 Step Detect Associates
3M
3test
77 Elektronika Kft
Abaxis Inc
Abbott
Abbott Diagnostics
Abbott Laboratories
Abbott Point of Care
AbbVie
AccuBioTech Co., Ltd.
Accumetrics
Accutech
Acon Laboratories
Acrongenomics Inc.
Adams Business Associates (ABA)
Advanced Care
Advanced Liquid Logic
Advanced MicrodevicesPvt. Ltd.
Aerscher Diagnostics
AgaMatrix Inc.
Agendia
Aimedics (Australia)
Akers Biomedical
Alere Inc.
Alfa Scientific Designs, Inc.
Alfa Wassermann Diagnostic Technologies, LLC
All Medicus
Alliance International Co., Ltd.
Amedica Biotech
American Bio Medica Corp
AmeriTek
Amgenix International Inc
AMICAS Corp
Ampcor
Analyticon Biotechnologies AG
Ani Biotech
Ani Biotech/Ani Laboratories
Answer
Apex Biotechnology Corp.
Applied Microarrays
ARJ Medical
ARKRAY, Inc.
Arlington Scientific, Inc.
Artron Laboratories
AspenBioPharma, Inc.
Astra Zeneca
Ativa Medical
Atlas Genetics
Atlas Link Biotech Co., Ltd.
Atonomics A/S
Audit Diagnostics
Autobio Diagnostics Co., Ltd.
Aventir Biotech
Aware Oral OTC - Calypte Biomedical
Axis-Shield plc
Axxin
AZOG, Inc.
B.R.A.H.M.S. AG
Bain Capital
Barr Pharmaceuticals
Bayer
BBI Healthcare
Bbraun
BC Partners
BD Biosciences
Beckman Access
Beckman Coulter Inc.
Becton, Dickinson and Company (BD)
Bio-AMD
Biofire Diagnostics
BioHelix Corporation
bioLytical Laboratories
BioMeditech Corporation
BioMerieux
Bionime
Bio-Rad Laboratories Inc.
BioSign
Biosite
Blackstone Group
Boditech
Boditechmed
Boehringer Ingelheim
Buying Solutions
C8 Medisensor
Calypte Biomedical Co
Cantimer
CardioGenics
Carlyle Group
Cepheid
CHEMBIO DIAGNOSTIC SYSTEMS, INC
Chugai Pharmaceuticals
Church & Dwight (CHD)
Clearview
CLIA laboratory
CoaguSense
Core Diagnostics
Dade Behring
Daktari Diagnostics
Danaher
Danaher Corporation
Decision Diagnostics Corp.
Dexcom
Diabetic Supply of Suncoast
Diagnostic Devices
Diagnostics for the Real World
DiME
e2v Biosensors
Early Pregnancy Tests.com
EIDIA
Eisai
EKF-diagnostic Gmb
Entegrion
Entra Health Systems
Epocal Inc
Expression Diagnostics
EY Laboratories
Fifty50 Medical
First Medical
Fisher Scientific
Focus Diagnostics
Fora Care
GeneDiagnostics Inc.
Genentech
General Life Biotechnology Ltd
Genesis Health Technology
Genomic Healthcare Strategies (GHS)
Genzyme
GlaxoSmtihKline (GSK)
Gluco Com
Grifols
Helena Laboratories
Helena Point of Care
Hema technologies
HemoCue
Hologic Inc
Home Diagnostics, Inc. (HDI)
Horiba
Ibis Biosciences
IDEV Technologies
IME-DC
Immucor
IND Diagnostics
Infopia
Innotrac
Insight Pharmaceuticals
Instrumentation Laboratory
Integrity Applications Ltd.
Inverness Medical Innovations (Alere)
IQuum
JANT Pharmacal Corporation
Johnson & Johnson (J&J)
Johnson & Johnson LifeScan
Johnson & Johnson's Ortho Clinical Diagnostics unit (OCD)
KKR & Co
Leeds and Partners
Lifescan Inc.
LifeSign
MBio Diagnostics
Mechanical Heart Valve Support Group
Medco Health Solutions
Medix Biochemica
Medmira Inc
Medtronic Ltd
Meikang Biotech
Menarini
Mendor
Merck
Meridian Bioscience
Micronics (acquired by Sony Corporation)
Mitsubishi Chemical
Mitsubushi Chemical Medience
MIZUHO MEDY Company
MobileLink
MyoCheck
NanoEntek
Nanogen
Nanomix, Inc.
Nanosphere, Inc.
Nestle
Nipro Diagnostics
Nova Biomedical
Novartis AG
Novescia Network of laboratories
Oak Tree International Holdings
Olympus
OnSight
OptiMedica Corporation
OraSure Technologies, Inc.
OrSense
Ortho-Clinical Diagnostics
Partec
Partec GmbH
PathWorks Diagnostics
Pfizer
PharmaTech Solutions, Inc.
PointCare Technologies Inc
Polymer Technology Systems Inc
Portola Pharmaceuticals
Procter and Gamble (P&G)
Prometheus Laboratories
Proteome Systems
Qiagen N.V.
Quest Diagnostics
QuickMedical
Quidel Corporation
Radiometer Medical ApS
Remel
Response Biomedical Corporation
Roche
Roche Diabetes Care (RDC)
Roche Diagnostics Corporation
Roche Holdings
Royal Philips Electronics
Runbio Biotech Company
SA Scientific
Sanofi
Savyon Diagnostics
Sekisui Medical Company
Siemens
Siemens AG
Siemens Diagnostics
Siemens Healthcare Diagnostics
Spirit Healthcare
STARLIMS Technologies
Suyog Diagnostics
Swiss Precision Diagnostics GmbH (SPD)
Symphony
Sysmex
SysmexCorporationThermo Scientific
T2 BioSystems
Teva
Therapeomics
Thermo Cardiosystems
Thermo Electron Corporation
Thermo Fisher Scientific Inc
Thoratec Corporation
Tocagen
Transasia Bio-Medicals
Triage
Trinity Biotech
Trovagene
U.S. Diagnostics
UL International GmbH
Universal Biosensors (UBI)
Universal Diagnostics
Ventana
Vermillion
Wall Greens
Wal-mart
Warburg Pincus
Wave 80 Biosciences
Werfen Group
Wilex
YD Diagnostics
Ypsomed
Zyomyx

【レポートのキーワード】

POC診断、POC検査

★調査レポート[ポイントオブケア(POC)診断市場(2014-2024)] ( The Point of Care Diagnostics Market Forecast 2014-2024 / Visiongain-405313) 販売に関する免責事項
[ポイントオブケア(POC)診断市場(2014-2024)] ( The Point of Care Diagnostics Market Forecast 2014-2024 / Visiongain-405313) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆